A Study of Pyridostigmine in Postural Tachycardia Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Postural Tachycardia Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Toni Gehrking) · adc.research@mayo.edu · 507-284-0336
    Contact: Principal Investigator (Wolfgang Singer, M.D.)
Study leads
  • Wolfgang Singer, M.D.

    Principal Investigator

    Mayo Clinic